Paclitaxel plus Ifosfamide in Advanced Ovarian Cancer
Autor: | G. Foglia, Gisella Pastorino, E Catsafados, Fulvio Brema, Francesco Boccardo, Domenico Guarneri, Nicola Ragni, Domenico Amoroso, L. Moraglio, F. Pedulla, C Granetto, S. Mammoliti, M.C. Martini, G.F. Addamo, Milena Bruzzone, Loredana Miglietta |
---|---|
Rok vydání: | 1997 |
Předmět: |
Gynecology
Cisplatin Oncology Cancer Research medicine.medical_specialty Chemotherapy Ifosfamide business.industry medicine.medical_treatment Phases of clinical research General Medicine medicine.disease Nitrogen mustard chemistry.chemical_compound chemistry Paclitaxel Internal medicine Carcinoma Medicine business Ovarian cancer medicine.drug |
Zdroj: | Oncology. 54:102-107 |
ISSN: | 1423-0232 0030-2414 |
DOI: | 10.1159/000227671 |
Popis: | Background: While ovarian cancer is one of the most sensitive cancers to cytotoxic drugs, with objective response rates of 60-80% routinely being reported in previously untreated pa |
Databáze: | OpenAIRE |
Externí odkaz: |